# Prevail Global Study

> **NCT06535854** · NA · RECRUITING · sponsor: **Medtronic Vascular** · enrollment: 1205 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Prevail DCB
- **DEVICE:** Agent DCB

## Key facts

- **NCT ID:** NCT06535854
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2027-02
- **Final completion:** 2031-02
- **Target enrollment:** 1205 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06535854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06535854, "Prevail Global Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06535854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*